These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1721461)

  • 1. Effects of FK 506 on acute experimental allergic encephalomyelitis.
    Deguchi K; Takeuchi H; Miki H; Yamada A; Touge T; Terada S; Nishioka M
    Transplant Proc; 1991 Dec; 23(6):3360-2. PubMed ID: 1721461
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of novel immunosuppressant FK 506 in acute experimental allergic encephalomyelitis].
    Deguchi K; Takeuchi H; Miki H; Yamada A; Touge T; Terada S; Nishioka M
    No To Shinkei; 1990 Apr; 42(4):391-7. PubMed ID: 1697182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoaugmenting effect of FK 506 on experimental allergic encephalomyelitis in Lewis rats.
    Chelmicka-Schorr E; Wiegmann K; Wollmann R; Arnason BG; Kim DH
    J Autoimmun; 1998 Aug; 11(4):329-34. PubMed ID: 9776710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evoked potentials (EPs) in experimental allergic encephalomyelitis: a study of EP modifications during the course of a controlled disease.
    Onofrj M; Gambi D; Bazzano S; Colamartino P; Fulgente T; Malatesta G; Ferracci F
    Electromyogr Clin Neurophysiol; 1992 Mar; 32(3):125-35. PubMed ID: 1555527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute allergic encephalomyelitis (EAE) in the rat with special reference to immunologic and demyelinization effects.
    Piliero SJ; Cremonese P
    J Reticuloendothel Soc; 1973 Jul; 14(1):100-18. PubMed ID: 4126715
    [No Abstract]   [Full Text] [Related]  

  • 6. A morphologic comparison of three experimental models of experimental allergic encephalomyelitis with multiple sclerosis.
    Shaw CM; Alvord EC
    Prog Clin Biol Res; 1984; 146():61-6. PubMed ID: 6201924
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of amphetamine and cocaine on the development of acute experimental allergic encephalomyelitis in Lewis rats.
    Núñez MJ; Balboa J; Rey-Méndez M; Brenlla J; González-Peteiro M; Rodrigo E; Freire-Garabal M
    Hum Exp Toxicol; 2007 Aug; 26(8):637-43. PubMed ID: 17884951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ability of myelin basic protein-sensitised leukocytes to adoptively transfer experimental allergic encephalomyelitis following coculture with FK 506, cyclosporine, or prednisolone.
    Bolton C
    Transplant Proc; 1991 Dec; 23(6):3363-4. PubMed ID: 1721462
    [No Abstract]   [Full Text] [Related]  

  • 9. Elevated levels of nerve growth factor in the thalamus and spinal cord of rats affected by experimental allergic encephalomyelitis.
    Micera A; De Simone R; Aloe L
    Arch Ital Biol; 1995 Mar; 133(2):131-42. PubMed ID: 7625888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic effects of cisplatin on rat experimental autoimmune encephalomyelitis.
    Li XB; Schluesener HJ
    Arch Immunol Ther Exp (Warsz); 2006; 54(1):51-3. PubMed ID: 16642257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental allergic encephalomyelitis in triethyltin sulfate-treated brown Norwegian and Lewis rats.
    Graham DI; Gonatas NK; Gasser DL
    Lab Invest; 1974 Jul; 31(1):24-8. PubMed ID: 4135588
    [No Abstract]   [Full Text] [Related]  

  • 12. The control of experimental allergic encephalomyelitis with retinoic acid. Further studies.
    Massacesi L; Abbamondi AL; Sarlo F; Amaducci L
    Riv Neurol; 1987; 57(3):166-9. PubMed ID: 3499654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurological signs in inflammatory demyelination.
    Pender MP
    Ann Neurol; 1993 May; 33(5):559-60. PubMed ID: 7684584
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclophosphamide treatment of experimental allergic encephalomyelitis in Lewis rats.
    Paterson PY
    J Immunol; 1971 Jun; 106(6):1473-9. PubMed ID: 4996791
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of macrophage depletion on the clinical and pathologic expression of experimental allergic encephalomyelitis.
    Brosnan CF; Bornstein MB; Bloom BR
    J Immunol; 1981 Feb; 126(2):614-20. PubMed ID: 6256443
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapeutic effects of melengestrol acetate, cyclophosphamide and palmitoyl cytarabine in established experimental allergic encephalomyelitis of rats.
    Elliott GA; Gibbons AJ; Greig ME
    Arch Int Pharmacodyn Ther; 1973 Jul; 204(1):62-76. PubMed ID: 4126903
    [No Abstract]   [Full Text] [Related]  

  • 17. Beta-adrenoceptor blockade ameliorates the clinical course of experimental allergic encephalomyelitis and diminishes its aggravation in adrenalectomized rats.
    Dimitrijević M; Rauski A; Radojević K; Kosec D; Stanojević S; Pilipović I; Leposavić G
    Eur J Pharmacol; 2007 Dec; 577(1-3):170-82. PubMed ID: 17854797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-12 induces relapse in experimental allergic encephalomyelitis in the Lewis rat.
    Smith T; Hewson AK; Kingsley CI; Leonard JP; Cuzner ML
    Am J Pathol; 1997 Jun; 150(6):1909-17. PubMed ID: 9176384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental allergic encephalomyelitis in inbred lines of chickens.
    Karakoz I; Blaszczyk B; Gieldanowski J
    Folia Biol (Praha); 1977; 23(6):396-7. PubMed ID: 608475
    [No Abstract]   [Full Text] [Related]  

  • 20. Calf thymus extract attenuates severity of experimental encephalomyelitis in Lewis rats.
    Zimecki M; Artym J; Kocięba M; Kuryszko J; Kaleta-Kuratewicz K; Marycz K
    Folia Neuropathol; 2010; 48(4):246-57. PubMed ID: 21225507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.